Your contact

Elisabeth Harbich

Project Management Start-up Support

From science to venture

Are you a biomedical founding team ready to take your idea to the next level? Join our BioEntrepreneur Bootcamp 2026 –  – a biomedical start-up business training program in Munich designed to help you develop, validate, and accelerate your business concept.

Date: 3 February 2026 to 26 March 2026

Time:  Seven weeks, Tuesday-Thursday, full day

Location: Hybrid (virtually & BioM, Am Klopferspitz 19a, 82152 Martinsried-Planegg)

Costs: free for pre-seed teams from Bavaria

Pricing

  • Start-up teams from Bavaria 99 € 
  • Pre-seed / start-ups international 199 €

NO SHOW FEE:  for all teams 99 €

Application Period:  3 - 26 November 2025

Over seven weeks (sessions running from Tuesday to Thursday), participants engage in:

  • 9 on-site days in Munich
  • 12 full-day online sessions
  • Plus, off-site teamwork on validation, strategy, and pitching etc.

Please apply via the following link: Application form BioM Bootcamp

Who should apply?

Pre-seed biomedical teams with an innovative idea in:

  • Drugs and therapies 
  • Biotechnology diagnostics, prediction, or prognosis platforms
  • Drug discovery & development technologies platforms

What you gain:

  • Validate your concept with industry experts and potential partners
  • Strengthen your team and business roadmap
  • Learn about funding, IP, regulations, and deal-making essentials
  • Connect with mentors, investors, and pharma leaders

Why join?

  • Learn from top experts and gain hands-on expertise in business strategy, IP, financing, regulation, and partnering
  • Work with mentors throughout the program 
  • Pitch to an expert jury at the final Demo Day
  • Expand your stakeholder network 
  • Make sure your business model meets real market needs

Because every great idea deserves a great launchpad!


More on the topic

07.04.2026
Gilead acquires Munich-based biotech company and m4 Award winner Tubulis for up to $5 billion
American biopharmaceutical company Gilead Sciences, located in California, is acquiring the Munich-based biotechnology company Tubulis, thereby further expanding its oncology pipeline. The…
Gilead acquires Munich-based biotech company and m<sup>4</sup> Award winner Tubulis for up to $5 billion
25.03.2026
BayOConnect 2026: Agenda Expanded with New Sessions, Speakers and Perspectives – Registration Now Open for Europe’s Leading Biotech Forum
BayOConnect 2026 on 30 June - 1 July 2026 in Munich highlights what truly drives growth in biotechnology: Europe as a competitive innovation hub, capital turning innovation into scale, and…
BayOConnect 2026: Agenda Expanded with New Sessions, Speakers and Perspectives – Registration Now Open for Europe’s Leading Biotech Forum
25.03.2026
BIO-Europe Spring 2026 & LSX World Congress Europe: BioM taking part in the Spring Innovation Week
BioM took part in BIO‑Europe Spring 2026 and LSX World Congress Europe in Lisbon, representing the Bavarian biotech ecosystem on the international stage. The conferences once again offered an…
BIO-Europe Spring 2026 & LSX World Congress Europe: Bio<sup>M</sup> taking part in the Spring Innovation Week